Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 3
2011 3
2012 3
2013 4
2014 4
2015 5
2016 5
2017 2
2018 7
2019 2
2020 2
2021 7
2022 5
2023 3
2024 4
2025 3
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Off-label use of quetiapine.
Mendes A. Mendes A. Br J Community Nurs. 2023 Oct 2;28(10):476. doi: 10.12968/bjcn.2023.28.10.476. Br J Community Nurs. 2023. PMID: 37793104 No abstract available.
Research encouraging off-label use of quetiapine: A systematic meta-epidemiological analysis.
Grabitz P, Saksone L, Schorr SG, Schwietering J, Bittlinger M, Kimmelman J. Grabitz P, et al. Clin Trials. 2024 Aug;21(4):418-429. doi: 10.1177/17407745231225470. Epub 2024 Jan 29. Clin Trials. 2024. PMID: 38284364
We aim to describe the way clinical studies fostered off-label prescription of the antipsychotic drug quetiapine (Seroquel). METHODS: In this systematic meta-epidemiological analysis, we searched EMBASE, MEDLINE, Cochrane CENTRAL and PsycINFO databases and included clinica …
We aim to describe the way clinical studies fostered off-label prescription of the antipsychotic drug quetiapine (Seroquel). METHODS: …
Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry.
Hefner G, Wolff J, Toto S, Reißner P, Klimke A. Hefner G, et al. J Neural Transm (Vienna). 2022 Nov;129(11):1353-1365. doi: 10.1007/s00702-022-02542-0. Epub 2022 Sep 7. J Neural Transm (Vienna). 2022. PMID: 36070009
The most often off-label prescribed drugs were quetiapine and mirtazapine for organic mental disorders (F0/G3), valproate and quetiapine in patients with disorders due to psychoactive substance use (F1), valproate in patients with psychotic disorders (F2), and rispe …
The most often off-label prescribed drugs were quetiapine and mirtazapine for organic mental disorders (F0/G3), valproate and quet …
Antipsychotics as antidepressants.
Roberts RJ, Lohano KK, El-Mallakh RS. Roberts RJ, et al. Asia Pac Psychiatry. 2016 Sep;8(3):179-88. doi: 10.1111/appy.12186. Epub 2015 May 12. Asia Pac Psychiatry. 2016. PMID: 25963405 Review.
Three second-generation antipsychotic (SGA) agents have received FDA approval for adjunctive treatment, to antidepressant, of major depressive disorder: quetiapine, aripiprazole, and olanzapine. Additionally, quetiapine and lurasidone have been approved for the trea …
Three second-generation antipsychotic (SGA) agents have received FDA approval for adjunctive treatment, to antidepressant, of major depressi …
Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality.
Berge J, Abri P, Andell P, Movahed P, Ragazan DC. Berge J, et al. J Psychiatr Res. 2022 May;149:352-358. doi: 10.1016/j.jpsychires.2021.11.023. Epub 2021 Nov 9. J Psychiatr Res. 2022. PMID: 34785037 Free article.
Olanzapine and quetiapine are routinely used off-label at lower doses, though it remains unclear whether treatment is associated with mortality. ...Individuals were followed for a total of 2.1 million person-years. Treatment with olanzapine/quetiapine occurred in 18 …
Olanzapine and quetiapine are routinely used off-label at lower doses, though it remains unclear whether treatment is associated with …
Off-label use of psychotropic drugs in youth.
Rosland HG, Wergeland GJ, Holst L. Rosland HG, et al. BMC Psychiatry. 2025 Jul 30;25(1):739. doi: 10.1186/s12888-025-07176-6. BMC Psychiatry. 2025. PMID: 40739649 Free PMC article.
The medicines that were most commonly prescribed were methylphenidate for hyperkinetic disorder, quetiapine for schizophrenia and bipolar disorder, sertraline for depressive disorder and anxiety/obsessive-compulsive disorder. ...
The medicines that were most commonly prescribed were methylphenidate for hyperkinetic disorder, quetiapine for schizophrenia and bip …
Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis.
Stogios N, Smith E, Bowden S, Tran V, Asgariroozbehani R, McIntyre WB, Remington G, Siskind D, Agarwal SM, Hahn MK. Stogios N, et al. Neuropsychopharmacology. 2022 Feb;47(3):664-672. doi: 10.1038/s41386-021-01163-7. Epub 2021 Aug 26. Neuropsychopharmacology. 2022. PMID: 34446830 Free PMC article.
Patients treated with olanzapine, risperidone, and quetiapine were more likely to report weight gain as a side effect and experience clinically significant ( 7%) weight gain compared to those treated with a placebo. Among studies that reported weight as a continuous outcom …
Patients treated with olanzapine, risperidone, and quetiapine were more likely to report weight gain as a side effect and experience …
Low to moderate-dose off-label use of second-generation antipsychotics seems to be safe in the light of cardiac adverse effects in child psychiatric patients.
Kakko K, Salmelin R, Puura K, Poutanen T. Kakko K, et al. Eur J Pediatr. 2025 Sep 11;184(10):609. doi: 10.1007/s00431-025-06447-4. Eur J Pediatr. 2025. PMID: 40932558 Free PMC article.
In all of them SGA (risperidone, aripiprazole, quetiapine) treatment was off-label. The median olanzapine equivalent dose was 2.0 mg. Concurrent ADHD medication was used by 40%. ...
In all of them SGA (risperidone, aripiprazole, quetiapine) treatment was off-label. The median olanzapine equivalent dose was 2.0 mg. …
Efficacy of quetiapine off-label uses: data synthesis.
Carney AC. Carney AC. J Psychosoc Nurs Ment Health Serv. 2013 Aug;51(8):11-8. doi: 10.3928/02793695-20130709-01. Epub 2013 Jul 18. J Psychosoc Nurs Ment Health Serv. 2013. PMID: 23848159 Review.
Quetiapine (Seroquel( )) is a potent U.S. Food and Drug Administration (FDA)-approved antipsychotic agent that has been used extensively for off-label indications. ...The strongest evidence exists for anxiety and delirium. Moderate evidence exists for quetiapine as …
Quetiapine (Seroquel( )) is a potent U.S. Food and Drug Administration (FDA)-approved antipsychotic agent that has been used extensiv …
60 results